Aerie Pharmaceuticals Stock Price - AERI

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
After Hours
Last Trade
Last $ 21.44 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Aerie Pharmaceuticals Inc AERI NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.40 1.9% 21.44 21.78 20.8218 20.99 21.04 16:39:57
Bid Price Ask Price Spread Spread % News
18.61 21.60 2.99 13.84% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
8,505 807,627 $ 21.36 $ 17,254,178 1,133,601 17.15 - 52.00
Last Trade Time Type Quantity Stock Price Currency
16:52:28 2 $ 20.54 USD

Aerie Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 993.13M 46.32M $ -232.57M -5.52 - 45.48M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 5.00 1.80%

more financials information »

Aerie Pharmaceuticals News

Loading Messages....

Latest AERI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AERI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week18.5921.7818.4419.951,020,7572.8515.33%
1 Month19.0121.7817.1519.02827,7202.4312.78%
3 Months23.8524.8217.1520.191,204,478-2.41-10.1%
6 Months35.2535.7417.1522.051,096,142-13.81-39.18%
1 Year39.6852.0017.1529.00855,241-18.24-45.97%
3 Years36.4074.7517.1541.86588,254-14.96-41.1%
5 Years30.9674.758.831133.40628,233-9.52-30.75%

Aerie Pharmaceuticals Description

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on discovery, development, and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Its main products are Rhopressa and Roclatan. The company mainly operates in North America.


Your Recent History
NASDAQ
AERI
Aerie Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.